Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026)
Tarsus Pharmaceuticals (TARS) reported Receivables - Other of $2.28 million for Q2 2026, up 19.7% from $1.91 million a year earlier but down 86.5% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Receivables - Other (2019 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals posted Receivables - Other of $2.05 million, up 58.0% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of 152.5% (FY2020 to FY2025).
- By year, Receivables - Other came in at $1.3 million in FY2024 (+18.8%), $1.09 million in FY2023 (-69.5%), $3.58 million in FY2022 and $92,000 in FY2021 (+360.0%).
- Five-year quarterly Receivables - Other spans a low of $92,000 in Q4 2021 and a high of $16.86 million in Q1 2026.
- Year over year, Receivables - Other has now increased in each of the last ten quarters, with growth averaging 137.3% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q1 2026 (growth of 876.4%); the low point was Q1 2022 (a decline of 95.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $16.86 million (Q1 2026), $2.05 million (Q4 2025) and $1.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn |
| 10 | Tarsus Pharmaceuticals | 3.11 Bn | 2.06 Bn | 161.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 246,000.00 |
| Mar 31, 2023 | 418,000.00 |
| Dec 31, 2022 | 3.58 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 603,000.00 |
| Mar 31, 2022 | 306,000.00 |
| Dec 31, 2021 | 92,000.00 |
| Sep 30, 2021 | 139,000.00 |
API Access
Tarsus Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();